119 related articles for article (PubMed ID: 4345099)
1. Chemotherapeutic management of the hormone-secreting endocrine malignancies.
Schein PS
Cancer; 1972 Dec; 30(6):1616-26. PubMed ID: 4345099
[No Abstract] [Full Text] [Related]
2. Chemotherapy of endocrine malignancies: a review.
Kvols LK; Buck M
Semin Oncol; 1987 Sep; 14(3):343-53. PubMed ID: 2820064
[No Abstract] [Full Text] [Related]
3. Endocrine tumors.
Averbuch SD
Cancer Chemother Biol Response Modif; 1991; 12():491-508. PubMed ID: 1681844
[No Abstract] [Full Text] [Related]
4. [Streptozotocin in hormone-active metastasizing islet-cell carcinoma].
Spech HJ; Wernze H; Brunswig D
Med Klin; 1973 Apr; 68(17):555-9. PubMed ID: 4350157
[No Abstract] [Full Text] [Related]
5. Chemotherapy of metastatic carcinoid and islet cell tumors. A review.
Kvols LK; Buck M
Am J Med; 1987 May; 82(5B):77-83. PubMed ID: 3035924
[No Abstract] [Full Text] [Related]
6. Editorial: Streptozotocin for islet-cell carcinoma.
Lancet; 1973 Nov; 2(7837):1063-4. PubMed ID: 4127316
[No Abstract] [Full Text] [Related]
7. Endocrine tumors.
Lamberts SW
Cancer Chemother Biol Response Modif; 1999; 18():388-93. PubMed ID: 10800494
[No Abstract] [Full Text] [Related]
8. [Indications and medical therapy of hypoglycemic beta-insular].
Patrassi N; Basoli A; Mineo TC; Carboni M
Folia Endocrinol; 1973 Oct; 26(5):361-6. PubMed ID: 4358211
[No Abstract] [Full Text] [Related]
9. Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.
Kraybill WG; Anderson DD; Lindell TD; Fletcher WS
Am Surg; 1976 Jul; 42(7):467-70. PubMed ID: 180857
[No Abstract] [Full Text] [Related]
10. Adrenal carcinoma.
Freeman DA
Curr Ther Endocrinol Metab; 1994; 5():155-7. PubMed ID: 7704704
[No Abstract] [Full Text] [Related]
11. ACTH, glucagon and gastrin production by a pancreatic islet cell carcinoma and its treatment.
Belchetz PE; Brown CL; Makin HL; Trafford DJ; Mason AS; Bloom SR; Ratcliffe JG
Clin Endocrinol (Oxf); 1973 Oct; 2(4):307-16. PubMed ID: 4358344
[No Abstract] [Full Text] [Related]
12. Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature.
Schein P; Kahn R; Gorden P; Wells S; Devita VT
Arch Intern Med; 1973 Oct; 132(4):555-61. PubMed ID: 4355081
[No Abstract] [Full Text] [Related]
13. Endocrine and metabolic diseases. Adrenal diseases.
Besser GM; Jeffcoate WJ
Br Med J; 1976 Feb; 1(6007):448-51. PubMed ID: 3256
[No Abstract] [Full Text] [Related]
14. Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma.
Moertel CG
Br J Cancer; 1976 Sep; 34(3):325-34. PubMed ID: 184809
[No Abstract] [Full Text] [Related]
15. Diazoxide, encorton and streptozotocin in the treatment of malignant betacytoma.
Tolloczko T; Wasiutyński A
Acta Med Pol; 1974; 15(1):69-77. PubMed ID: 4369916
[No Abstract] [Full Text] [Related]
16. [Cushing's syndrome. Medical treatment of adrenal hypercorticism].
Bricaire H; Luton JP
Horm Res; 1980; 13(4-5):317-24. PubMed ID: 7274999
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
[TBL] [Abstract][Full Text] [Related]
18. Treatment of insulinoma with streptozotocin.
Arnould Y; Ooms HA; Bastenie PA
Lancet; 1969 Jun; 1(7607):1210-1. PubMed ID: 4181857
[No Abstract] [Full Text] [Related]
19. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998).
Schein PS; O'Connell MJ; Blom J; Hubbard S; Magrath IT; Bergevin P; Wiernik PH; Ziegler JL; DeVita VT
Cancer; 1974 Oct; 34(4):993-1000. PubMed ID: 4371075
[No Abstract] [Full Text] [Related]
20. Endocrine tumours.
Lamberts SW
Cancer Chemother Biol Response Modif; 1997; 17():492-503. PubMed ID: 9551228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
